{
  "meta": {
    "title": "12_Bipolar_And_Related_Disorders",
    "url": "https://brainandscalpel.vercel.app/12-bipolar-and-related-disorders-703b46d3.html",
    "scrapedAt": "2025-11-30T12:35:17.057Z"
  },
  "questions": [
    {
      "text": "A man brings his wife to the psychiatric OPD, reporting concerns about her recent behaviour. She complains of irritability, distractibility, and reduced need for sleep. Her husband observes that she has an elated mood, talks excessively, and struggles to manage her daily activities. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Schizophrenia"
        },
        {
          "id": 2,
          "text": "Depression"
        },
        {
          "id": 3,
          "text": "Hypomania"
        },
        {
          "id": 4,
          "text": "Mania"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical history of decreased sleep, elation, talkativeness, irritability, and distractibility present for <strong>at least 1 week</strong> is characteristic of <strong>mania</strong>.</p>\n<p>Diagnostic criteria for mania:</p>\n<p>A. Distinct period of abnormally and persistently <strong>elevated/irritable mood</strong>, abnormally and persistently <strong>increased activity/energy</strong>, lasting <strong>at least 1 week </strong>or any duration if hospital­ization is necessary.</p>\n<p>B. During the period of mood disturbance and increased energy/activity, three (or more) of the following symptoms and four (or more) if irritable have been present to a significant degree:</p>\n<ol>\n<li>Inflated self-esteem or <strong>grandiosity</strong></li>\n<li>Decreased need for sleep</li>\n<li>More talkative than usual</li>\n<li><strong>Flight of ideas</strong></li>\n<li><strong>Distractibility</strong></li>\n<li>Increase in goal-oriented activity or psychomotor agitation</li>\n<li>Excessive involvement in activities that have a high potential for painful consequences</li>\n</ol>\n<p>C. The episode is severe enough to cause marked social or occupational <strong>impairment</strong> or to necessitate <strong>hospitalization.</strong></p>\n<p>D. The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication, other treatment) or to another medical condition.</p><hr><h3>Related Pearl: Mania Vs Hypomania</h3><table>\n<tbody>\n<tr>\n<td><strong>Mania</strong></td>\n<td><strong>Hypomania</strong></td>\n</tr>\n<tr>\n<td>Symptoms for at least 1 week</td>\n<td>Symptoms for at least 4 days</td>\n</tr>\n<tr>\n<td>Marked impairment in social or occupational functioning</td>\n<td>No impairment in social or occupational functioning</td>\n</tr>\n<tr>\n<td>May need hospitalization</td>\n<td>Doesn't need hospitalization</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6687",
      "difficulty": "easy"
    },
    {
      "text": "A 20-year-old male presents to the OPD with decreased sleep, elation and talkativeness for the past 5 days. He also complains of irritability and distractibility. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Mania"
        },
        {
          "id": 2,
          "text": "Anxiety disorder"
        },
        {
          "id": 3,
          "text": "Hypomania"
        },
        {
          "id": 4,
          "text": "Schizophrenia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of symptoms of mania occurring for <strong>at least&nbsp;4 days</strong>&nbsp;points towards a diagnosis of&nbsp;<strong>hypomania.</strong></p>\n<p>Diagnostic criteria for hypomania:</p>\n<p>A. Distinct period of abnormally and persistently <strong>elevated/irritable mood</strong>, abnormally and persistently <strong>increased&nbsp;activity/energy</strong>, lasting for&nbsp;<strong>at least 4 consecutive days</strong>.</p>\n<p>B.<strong>&nbsp;</strong>During the period of mood disturbance and increased energy and activity, three (or more) and&nbsp;if irritable, four (or more) of the following symptoms have been present to a significant degree:</p>\n<ol>\n<li>Inflated self-esteem or <strong>grandiosity</strong></li>\n<li>Decreased need for sleep</li>\n<li>More talkative than usual</li>\n<li><strong>Flight of ideas</strong></li>\n<li><strong>Distractibility</strong></li>\n<li>Increase in goal-oriented activity or psychomotor agitation</li>\n<li>Excessive involvement in activities that have a high potential for painful consequences (for example, foolish business investments).</li>\n</ol>\n<p>C. The episode is associated with an unequivocal change in functioning that is uncharac&shy;teristic of the individual when not symptomatic and is observable by others.&nbsp;</p>\n<p>D.&nbsp; The episode is <strong>not severe</strong> enough to cause marked impairment in social or occupational functioning or to necessitate hospitalization. <strong>No psychotic episodes</strong>.&nbsp;</p>\n<p>E.&nbsp;The episode is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication, other treatment) or to another medical condition.</p><hr><h3>Related Pearl: Mania Vs Hypomania</h3><table>\n<tbody>\n<tr>\n<td><strong>Mania</strong></td>\n<td><strong>Hypomania</strong></td>\n</tr>\n<tr>\n<td>Symptoms for at least 1 week</td>\n<td>Symptoms for at least 4 days</td>\n</tr>\n<tr>\n<td>Marked impairment in social or occupational functioning</td>\n<td>No impairment in social or occupational functioning</td>\n</tr>\n<tr>\n<td>May need hospitalization</td>\n<td>Doesn't need hospitalization</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0978",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a previously diagnosed psychiatric disorder presented for a follow-up in the OPD. He had mood swings fluctuating between short periods of mild depression and hypomania over 3 years. What is this disorder known as?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclothymia"
        },
        {
          "id": 2,
          "text": "Bipolar I"
        },
        {
          "id": 3,
          "text": "Bipolar II"
        },
        {
          "id": 4,
          "text": "Dysthymia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cyclothymia </strong>is a&nbsp;chronic disorder characterized by at least&nbsp;<strong>2 years&nbsp;</strong>of fluctuating, <strong>mild</strong> hypomanic &amp; depressive <strong>symptoms</strong> (that do not meet the <strong>full criteria</strong> for hypomanic episodes or major depressive episodes). It is a symptomatically <strong>milder form </strong>of&nbsp;<strong>bipolar&nbsp;II&nbsp;disorder.</strong></p>\n<p><strong>Dysthymia&nbsp;</strong>(persistent depressive disorder) is characterized by at least 2 years of depressed mood that does not satisfy the criteria for a major depressive episode and with <strong>no episodes of mania or hypomania. </strong>In children, a diagnosis of dysthymia is made if depressive symptoms are present for more than 1 year.&nbsp;</p><hr><h3>Related Pearl: Bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td><span><strong> Bipolar &amp; related disorders </strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Manic episode</strong></span></p>\n<ul>\n<li><span>Symptoms more <strong>severe</strong></span></li>\n<li><span><strong>1 week</strong> unless hospitalized</span></li>\n<li><span><strong>Marked impairment</strong> in social or occupational functioning or <strong>hospitalization</strong> necessary</span></li>\n<li><span>May have <strong>psychotic features</strong>; makes episode manic by definition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hypomanic episode</strong> &nbsp;</span></p>\n<ul>\n<li><span>Symptoms <strong>less severe</strong></span></li>\n<li><span><strong>4 days&nbsp;</strong>to less than 7 days</span></li>\n<li><span>Unequivocal, observable change in functioning from patient's baseline</span></li>\n<li><span>Symptoms not severe enough to cause marked impairment or necessitate hospitalization</span></li>\n<li><span><strong>No psychotic features</strong></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar I</strong></span></p>\n<ul>\n<li><span><strong>Manic episode(s)</strong></span></li>\n<li><span>Depressive episodes common (but not required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar II</strong></span></p>\n<ul>\n<li><span><strong>Hypomanic episode(s)</strong></span></li>\n<li><span>Major depressive episodes (required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Cyclothymic disorder</strong></span></p>\n<ul>\n<li><span>At least <strong>2 years</strong> of fluctuating, mild hypomanic &amp; depressive symptoms that </span><br /><span>do not meet criteria for hypomanic episodes or major depressive episodes</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Patterns of Mood Disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ab1892272934b0792b8745017664ccfx1280x6841.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6692",
      "difficulty": "medium"
    },
    {
      "text": "As a first-year psychiatry resident, you see a patient diagnosed with bipolar type II disorder. Which of the following constitutes this disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Repeated episodes of mania"
        },
        {
          "id": 2,
          "text": "Mania + hypomania"
        },
        {
          "id": 3,
          "text": "Hypomania + major depression"
        },
        {
          "id": 4,
          "text": "Mania + major depression"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Episodes of <strong>hypomania and major depressive disorder</strong> constitute bipolar type II disorder.</p>\n<p>Types of bipolar disorder:</p>\n<p>Bipolar I: Episodes of <strong>mania with or without</strong> episodes of <strong>major depressive disorder</strong> (at least one-lifetime episode of mania is required for diagnosis)</p>\n<p>Bipolar II:<strong>&nbsp;</strong>Episodes of <strong>hypomania&nbsp;with</strong> episodes of <strong>major depressive disorder</strong> (negative history of a manic episode is required for diagnosis)</p><hr><h3>Related Pearl: Patterns of Mood Disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ab1892272934b0792b8745017664ccfx1280x6841.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6698",
      "difficulty": "easy"
    },
    {
      "text": "As an intern posted in psychiatry, you observe a patient with mania. Which of the following is true about neurotransmitters in this disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Decrease in serotonin"
        },
        {
          "id": 2,
          "text": "Decrease in norepinephrine"
        },
        {
          "id": 3,
          "text": "Increase in neuropeptide Y"
        },
        {
          "id": 4,
          "text": "Increase in norepinephrine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In mania, there is an <strong>increase in norepinephrine and dopamine</strong> levels.</p><hr><h3>Related Pearl: Neurotransmitters</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neuro-transmitters</strong></td>\n<td><strong>&nbsp;Major source</strong></td>\n<td><strong>&nbsp;Function</strong></td>\n<td><strong>&nbsp;Increased in</strong></td>\n<td><strong>&nbsp;Decreased in</strong></td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td><span>Midline Raphe Nucleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Regulation of mood, sleep, appetite, sexual behavior, decreases anxiety</span></p>\n<p><span>Inhibits the dopaminergic function</span></p>\n</td>\n<td><span>Serotonin syndrome</span></td>\n<td>\n<p><span>Depression</span></p>\n<p><span>OCD</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Dopamine</strong></td>\n<td>&nbsp;<span>Substantia Nigra</span></td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Motor movement and alertness</span></p>\n<p><span>Reward seeking, pleasure, motivation</span></p>\n<p><span>Major neurotransmitter in the basal ganglia</span></p>\n</td>\n<td>\n<p><span>Schizophrenia</span></p>\n<p><span>OCD</span></p>\n<p><span>Mania</span></p>\n<p><span>Delirium</span></p>\n</td>\n<td>\n<p><span>Parkinson's disease</span></p>\n<p><span>Depression</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Endorphins</strong></td>\n<td>&nbsp;<span>Pituitary gland</span></td>\n<td><span>Pain control, feelings of pleasure, stress reduction, \"natural opium\"</span></td>\n<td><span>Addiction</span></td>\n<td><span>Inability to combat pain</span></td>\n</tr>\n<tr>\n<td><strong>Acetylcholine</strong></td>\n<td>&nbsp;<span>Nucleus Basalis (of Meynert)</span></td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Motor movement, learning and memory</span></p>\n</td>\n<td><span>Parkinson's disease</span></td>\n<td>\n<p><span>Alzheimer's disease</span></p>\n<p><span>Delirium</span></p>\n<p><span>Dementia</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>GABA</strong></td>\n<td>&nbsp;\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Decreases anxiety and reduces insomnia</span></p>\n<p><span>Interacts with dopamine, inhibits dopaminergic neurons</span></p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p><span>Anxiety</span></p>\n<p><span>Seizure disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td><span>Locus ceruleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory:</strong></span></p>\n<p><span>\"Fight or flight\"</span></p>\n</td>\n<td><span>Mania</span></td>\n<td><span>Lack of energy, anhedonia in Schizophrenia,&nbsp;</span><span>Depression</span></td>\n</tr>\n<tr>\n<td><strong>Glutamate</strong></td>\n<td>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Links between neurons for learning and long term memory</span></p>\n</td>\n<td><span>Seizures</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6701",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statement is not true regarding the epidemiology of bipolar disorders?",
      "choices": [
        {
          "id": 1,
          "text": "The lifetime prevalence of bipolar disorder is around 1%"
        },
        {
          "id": 2,
          "text": "The average age of onset of bipolar I disorder is 30 years"
        },
        {
          "id": 3,
          "text": "Prevalence is equal among both the sexes"
        },
        {
          "id": 4,
          "text": "Prevalence is higher in higher socio-economic strata"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>average age of onset</strong> of <strong>bipolar I</strong> disorder<strong>&nbsp;</strong>is<strong>&nbsp;20 years, </strong>and in more than half of the cases, the onset is frequently in late adolescence.</p>\n<p>The <strong>lifetime prevalence&nbsp;</strong>of bipolar disorder is<strong> 1.2%&nbsp;</strong>and prevalence is <strong>equal in both genders</strong> (unlike depression, which has a higher prevalence among females than males).</p>\n<p>The prevalence of bipolar disorder is higher in <strong>higher socio-economic strata. </strong>By contrast, schizophrenia has a higher prevalence in the lower socio-economic strata.</p>\n<p>Note:&nbsp;The mean age of onset of depression is 40 years.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6929",
      "difficulty": "hard"
    },
    {
      "text": "A 40-year-old patient comes to the OPD with a history significant for a mood disorder. Her moods can be charted as done in the image given below. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclothymia"
        },
        {
          "id": 2,
          "text": "Dysthymia"
        },
        {
          "id": 3,
          "text": "Rapid cycling disorder"
        },
        {
          "id": 4,
          "text": "Hypomania"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">The given image showing 3 episodes of mania and 2 episodes of depression&nbsp;<strong>within 1 year,</strong> points towards a diagnosis of <strong>rapid cycling bipolar disorder</strong>.&nbsp;</p>\n<p class=\"p1\">It is diagnosed when the patient has a combination of&nbsp;<strong>4 or more</strong>&nbsp;<strong>alternating episodes</strong> of <strong>depression and mania/hypomania</strong> within <strong>one</strong>&nbsp;<strong>year</strong>. There must be less than 2 weeks of normalcy between the episodes or an immediate shift between the symptoms with no intervening normal mood.</p>\n<p>Risk factors:</p>\n<ul>\n<li>Female patients</li>\n<li>Hypothyroidism</li>\n<li>Alcoholism or substance abuse</li>\n<li>Antidepressants (if used without mood stabilizers)</li>\n<li>Cyclothymia</li>\n<li>Bipolar II disorder</li>\n</ul>\n<p>Note:&nbsp;If the phases of mania and depression <strong>alternate</strong> very rapidly in a matter of<strong> hours or days </strong>then&nbsp;the condition is known as <strong>ultra-rapid cycling disorder</strong>.</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;World Bipolar Day (WBD) is celebrated each year on March 30th to bring world awareness about bipolar disorders and to eliminate the social stigma. The theme for this year is \\&quot;BipolarTogether\\&quot;&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:829,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0}\"><strong>World Bipolar Day</strong> (WBD) is celebrated each year on March 30th to bring world awareness about bipolar disorders and to eliminate the social stigma. The theme for the year 2023 is <strong>\"BipolarTogether\"</strong></span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6ef2c052148a45efad412d06715a505b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6700",
      "difficulty": "easy"
    },
    {
      "text": "As a first-year psychiatry resident, you are consulting on a young man with depression. Which of the following would you not expect to see in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Delusions"
        },
        {
          "id": 2,
          "text": "Flight of ideas"
        },
        {
          "id": 3,
          "text": "Early morning awakening"
        },
        {
          "id": 4,
          "text": "Hallucination"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Flight of ideas</strong> is a <strong>sign of mania</strong> and is not seen in depression.</p>\n<p>Early morning awakening is also known as <strong>terminal insomnia</strong> and is seen in&nbsp;<strong>depression</strong>.</p>\n<p>Severely depressed patients sometimes present with mood-congruent&nbsp;<strong>delusions or hallucinations&nbsp;</strong>and are said to have a <strong>major depressive episode with psychotic features</strong>.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Mood congruent psychotic features</td>\n<td>Mood incongruent psychotic features</td>\n</tr>\n<tr>\n<td>Consistent with the mood</td>\n<td>Not consistent with the mood</td>\n</tr>\n<tr>\n<td>Occurs in mood disorders with psychotic features</td>\n<td>Occurs in schizophrenia</td>\n</tr>\n<tr>\n<td>\n<p>E.g.,<strong>&nbsp;</strong>Delusions of guilt, sinfulness,<br />worthlessness, poverty, failure, persecution, and command hallucinations to kill oneself,&nbsp;in a person with a depressed mood.</p>\n</td>\n<td>\n<p>E.g.,<strong>&nbsp;</strong>Delusion of exaggerated power, knowledge, and worth&nbsp;in a person with a depressed mood</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6678",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a risk factor for rapid cycling in bipolar disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Female sex"
        },
        {
          "id": 2,
          "text": "Hypothyroidism"
        },
        {
          "id": 3,
          "text": "Use of antidepressants"
        },
        {
          "id": 4,
          "text": "BPAD 1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Bipolar affective disorder II</strong> (BPAD II) is a risk factor of <strong>rapid cycling</strong> (not BPAD I).&nbsp;</p>\n<p>Risk factors for developing rapid cycling include:</p>\n<ul>\n<li>Female patients</li>\n<li>Hypothyroidism</li>\n<li>Alcoholism or substance abuse</li>\n<li>Antidepressants (if used without mood stabilizers)</li>\n<li>Cyclothymia</li>\n<li>Bipolar II disorder</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8407",
      "difficulty": "medium"
    },
    {
      "text": "A 21-year-old was brought to your OPD by his worried parents. He frequently states that he is more learned than all his professors and is on the verge of a breakthrough. He barely slept and spent long hours talking to his friends about the importance of his ideas. His parents confirmed that he had some periods of withdrawal and depression during his adolescence. What is the drug of choice for the maintenance therapy of this disorder?",
      "choices": [
        {
          "id": 1,
          "text": "Lithium"
        },
        {
          "id": 2,
          "text": "Valproic acid"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Anti-psychotics"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>bipolar disorder. Lithium</strong> is the <strong>drug of choice</strong> for <strong>maintenance</strong> therapy&nbsp;of bipolar disorder.</p>\n<p>It is also the most effective long-term treatment choice for bipolar disorder.&nbsp;</p><hr><h3>Related Pearl: Bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td><span><strong> Bipolar &amp; related disorders </strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Manic episode</strong></span></p>\n<ul>\n<li><span>Symptoms more <strong>severe</strong></span></li>\n<li><span><strong>1 week</strong> unless hospitalized</span></li>\n<li><span><strong>Marked impairment</strong> in social or occupational functioning or <strong>hospitalization</strong> necessary</span></li>\n<li><span>May have <strong>psychotic features</strong>; makes episode manic by definition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hypomanic episode</strong> &nbsp;</span></p>\n<ul>\n<li><span>Symptoms <strong>less severe</strong></span></li>\n<li><span><strong>4 days&nbsp;</strong>to less than 7 days</span></li>\n<li><span>Unequivocal, observable change in functioning from patient's baseline</span></li>\n<li><span>Symptoms not severe enough to cause marked impairment or necessitate hospitalization</span></li>\n<li><span><strong>No psychotic features</strong></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar I</strong></span></p>\n<ul>\n<li><span><strong>Manic episode(s)</strong></span></li>\n<li><span>Depressive episodes common (but not required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar II</strong></span></p>\n<ul>\n<li><span><strong>Hypomanic episode(s)</strong></span></li>\n<li><span>Major depressive episodes (required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Cyclothymic disorder</strong></span></p>\n<ul>\n<li><span>At least <strong>2 years</strong> of fluctuating, mild hypomanic &amp; depressive symptoms that </span><br /><span>do not meet criteria for hypomanic episodes or major depressive episodes</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6703",
      "difficulty": "medium"
    },
    {
      "text": "What is the upper limit of serum lithium above which a patient is said to have lithium toxicity?",
      "choices": [
        {
          "id": 1,
          "text": "0.8 mEq/L"
        },
        {
          "id": 2,
          "text": "2.5 mEq/L"
        },
        {
          "id": 3,
          "text": "0.5 mEq/L"
        },
        {
          "id": 4,
          "text": "1.5 mEq/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Lithium toxicity is considered when the blood concentration reaches <strong>1.5 mEq/L&nbsp;</strong>(or more).&nbsp;</p>\n<p>Blood concentration of lithium in the treatment of mood disorders:</p>\n<ul>\n<li>For treatment:&nbsp;<strong>0.8 - 1.2 mEq/L</strong></li>\n<li>For prophylaxis:&nbsp;<strong>0.5 - 0.8 mEq/L</strong></li>\n<li>Toxic levels:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></li>\n</ul>\n<p>Manifestations of lithium toxicity:</p>\n<ul>\n<li>Acute: Coarse tremors (most common), delirium, dementia, seizures, and increase in deep tendon reflexes</li>\n<li>Chronic: Nephrotoxicity (lithium-induced nephrogenic diabetes insipidus), hypothyroidism</li>\n</ul>\n<p>The&nbsp;<strong>most effective</strong> means&nbsp;of treating lithium toxicity is&nbsp;<strong>dialysis</strong>. It is necessary for severe poisoning cases, where:</p>\n<ul>\n<li>The patient is exhibiting symptoms of toxicity, or</li>\n<li>Lithium concentration is 4 mEq/L or more.&nbsp;</li>\n</ul><hr><h3>Related Pearl: Lithium in bipolar disorder</h3><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6704",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old man with bipolar disorder comes to the clinic for a routine follow-up. His condition was difficult to control and required treatment with multiple medications over the past two years. The patient says his mood has been stable with his current regimen, but for the past three months, he has had tremors primarily affecting his hands. Which of the following drugs is the most likely cause?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Gabapentin"
        },
        {
          "id": 3,
          "text": "Lamotrigine"
        },
        {
          "id": 4,
          "text": "Lithium carbonate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p class=\"p1\"><strong>Lithium carbonate</strong> is most likely to cause the tremors described in the given scenario.</p>\n<p>Tremors are a common adverse effect of lithium carbonate<strong>.</strong>&nbsp;They are sometimes related to peak serum lithium levels.</p>\n<p>Dividing the dose of lithium carbonate and decreasing caffeine intake can decrease the severity of the tremors. In case of severe coarse tremors, lithium carbonate toxicity (serum lithium level greater than 2.5 mEq/L) must be ruled out.</p>\n<p>Options A and C:&nbsp;<strong>Carbamazepine</strong> and <strong>lamotrigine</strong> are off-label agents used&nbsp;for the management of bipolar disorder, however, they <strong>do not cause tremors.</strong></p>\n<p>Option B: Tremors may occur as an adverse effect of <strong>gabapentin</strong>, but it is <strong>not prescribed</strong> for the management of <strong>bipolar</strong> disorder.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6931",
      "difficulty": "easy"
    },
    {
      "text": "A patient comes to the OPD with a history significant of a mood disorder. His moods can be charted as shown in the image. What will be the best drug for him?",
      "choices": [
        {
          "id": 1,
          "text": "Lamotrigine"
        },
        {
          "id": 2,
          "text": "Sodium valproate"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Lithium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient has&nbsp;<strong>rapid-cycling bipolar disorder.</strong> <strong>Sodium valproate </strong>is the<strong> drug of choice </strong>for&nbsp;this disorder.</p>\n<p>Diagnosis of rapid-cycling bipolar disorder:</p>\n<ul>\n<li><strong>4 or more</strong> mood disturbances in a year</li>\n</ul>\n<p>Episodes either have a partial or full <strong>remission</strong> for at least 2 months <strong>or switch</strong> to the opposite <strong>polarity<br /><br /></strong></p>\n<p>Other options:</p>\n<p>Option A: Lamotrigine has been found to have limited uses in rapid-cycling bipolar disorder. It can prolong the time between depression and mania.</p>\n<p>Option C: Carbamazepine takes 2-3 weeks for the onset of action and is used in patients not responding to Lithium in Acute Mania.</p>\n<p>Option D: Lithium takes 5-7 days to achieve a level of equilibrium, moreover it is effective in Bipolar I disorder and is less efficacious than Divalproex in rapid-cycling bipolar disorder.</p>\n<p><strong>&nbsp;</strong></p><p>A recent trial found that increased levels of <strong>parathyroid hormone</strong> in patients with bipolar disorder were associated with <strong>worse clinical outcomes</strong>. Researchers suggest <strong>vitamin D supplementation</strong> as a possible <strong>add-on treatment</strong>.</p><hr><h3>Related Pearl: Patterns of Mood Disorders</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ab1892272934b0792b8745017664ccfx1280x6841.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f62508eedc264fe49919abadd54a55ea.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3246",
      "difficulty": "medium"
    },
    {
      "text": "A baby born to a woman taking prophylactic medication for manic disorder is cyanotic, lethargic, and hypotonic. Which other finding is the baby most likely to have?",
      "choices": [
        {
          "id": 1,
          "text": "Renal agenesis"
        },
        {
          "id": 2,
          "text": "Anencephaly"
        },
        {
          "id": 3,
          "text": "Tricuspid valve displacement"
        },
        {
          "id": 4,
          "text": "Ventricular septal defect"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical features are seen in&nbsp;<strong>Ebstein's anomaly. </strong>This&nbsp;is a rare congenital cyanotic heart disease caused by the&nbsp;downward <strong>displacement</strong>&nbsp;of the <strong>tricuspid</strong>&nbsp;<strong>valve</strong> into the right ventricle.&nbsp;It is a <strong>teratogenic effect of lithium</strong>, a&nbsp;drug used for prophylaxis in&nbsp;manic disorder.</p>\n<p>Lithium is thus <strong>avoided </strong>in the <strong>first trimester</strong> and during <strong>lactation</strong>. An antipsychotic like olanzapine should be considered instead of prophylactic management.</p>\n<p>If lithium is to be continued, then:</p>\n<ul>\n<li>The dose should be tapered to the lower end of the therapeutic range</li>\n<li>It should be given in divided doses</li>\n<li>The levels should be checked <strong>every two weeks</strong></li>\n<li>The woman should be hydrated well throughout labour</li>\n<li>Withholding lithium therapy for <strong>24-48 hours before delivery</strong> is recommended</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3235",
      "difficulty": "medium"
    }
  ]
}